Skip to Content

MYLAN TM 180 MYLAN TM 180 (Temozolomide 180 mg)

Pill with imprint MYLAN TM 180 MYLAN TM 180 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Mylan Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN TM 180 MYLAN TM 180

Temozolomide 180 mg MYLAN TM 180 MYLAN TM 180

Temozolomide

Imprint
MYLAN TM 180 MYLAN TM 180
Strength
180 mg
Color
Orange & White
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5264
Inactive Ingredients
silicon dioxide, lactose anhydrous, sodium starch glycolate type A potato, stearic acid, tartaric acid, ammonia, ferrosoferric oxide, propylene glycol, shellac, gelatin, titanium dioxide, ferric oxide red, ferric oxide yellow, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.